Antiviral Drugs Market size was over USD 54.13 Billion in 2023 and is poised to exceed USD 91.27 Billion by the end of 2036, growing at over 4.1% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of antiviral drugs is estimated at USD 56.13 Billion. The increasing cases of hepatitis B infection and high investment in R&D activities on antiviral drugs across the world are estimated to propel the market growth during the forecast period. As per the World Health Organization, about 296 million people are suffered from chronic hepatitis B infection in 2019.
The growing incidence rate of infectious diseases such as herpes simplex virus, hepatitis virus, and influenza. As per the observations, between September to October 2022, nearly 5300 members tested positive for the influenza virus.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?